Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele De Simone

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Cancers|April 3, 2021
A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal CarcinomatosisManuela Robella, Michele De Simone, Paola Berchialla, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 23, 2009
Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOCMaribel L Sierra, Alberto Agazzi, Lisa Bodei, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2005
Early activation of vascular endothelial cells and platelets in obese childrenGiovambattista Desideri, Michele De Simone, Lorenzo Iughetti, et al.
In Vivo (Athens, Greece)|January 6, 2007
Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized studyGiammaria Fiorentini, Maurizio Cantore, Susanna Rossi, et al.
Oncotarget|March 31, 2016
Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancerJessica Erriquez, Martina Olivero, Gloria Mittica, et al.
Journal of Cancer Research and Clinical Oncology|October 18, 2019
Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort studyStefano Guadagni, Giammaria Fiorentini, Michele De Simone, et al.
Cancers|January 21, 2023
Diagnostic and Therapeutic Pathway of Advanced Ovarian Cancer with Peritoneal MetastasesValentina Ghirardi, Anna Fagotti, Luca Ansaloni, et al.
Journal of Ovarian Research|May 31, 2018
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experienceEleonora Ghisoni, Dionyssios Katsaros, Furio Maggiorotto, et al.
Cancers|June 12, 2020
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional ProfilesClaudio Isella, Marco Vaira, Manuela Robella, et al.
Cancers|February 11, 2023
Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal MesotheliomaShigeki Kusamura, Dario Baratti, Michele De Simone, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Cancers|April 3, 2021
A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal CarcinomatosisManuela Robella, Michele De Simone, Paola Berchialla, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 23, 2009
Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOCMaribel L Sierra, Alberto Agazzi, Lisa Bodei, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2005
Early activation of vascular endothelial cells and platelets in obese childrenGiovambattista Desideri, Michele De Simone, Lorenzo Iughetti, et al.
In Vivo (Athens, Greece)|January 6, 2007
Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized studyGiammaria Fiorentini, Maurizio Cantore, Susanna Rossi, et al.
Oncotarget|March 31, 2016
Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancerJessica Erriquez, Martina Olivero, Gloria Mittica, et al.
Journal of Cancer Research and Clinical Oncology|October 18, 2019
Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort studyStefano Guadagni, Giammaria Fiorentini, Michele De Simone, et al.
Cancers|January 21, 2023
Diagnostic and Therapeutic Pathway of Advanced Ovarian Cancer with Peritoneal MetastasesValentina Ghirardi, Anna Fagotti, Luca Ansaloni, et al.
Journal of Ovarian Research|May 31, 2018
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experienceEleonora Ghisoni, Dionyssios Katsaros, Furio Maggiorotto, et al.
Cancers|June 12, 2020
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional ProfilesClaudio Isella, Marco Vaira, Manuela Robella, et al.
Cancers|February 11, 2023
Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal MesotheliomaShigeki Kusamura, Dario Baratti, Michele De Simone, et al.
Pageof 6